公司资料
Novan 股价、新闻与催化剂
- 股票代码:
- NOVN
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for NOVN.
公司概览
业务概览
Novan was a dermatology-focused biotechnology company built around nitric oxide-based therapies for skin conditions and related inflammatory indications. Its story was centered on a narrow clinical platform and the challenge of turning topical science into a durable commercial path.
所在地与行业分类
Novan was headquartered in the United States and listed on NASDAQ, with a profile tied to dermatology and specialty biotech. It belonged to the small-cap development universe rather than a diversified pharma category.
商业模式特征
The business depended on clinical progress, regulatory milestones, and financing discipline more than on broad commercial diversification. Investors typically watched proof-of-concept data, development updates, and whether the company could advance a focused dermatology franchise.
生物医药行业定位
Novan occupied a legacy small-cap dermatology niche within biotech. Because it was highly dependent on a limited number of programs, the stock was always sensitive to execution, funding, and regulatory visibility.
未来催化剂
- Novan is also mostly a legacy / closeout story, with catalysts limited to any residual asset or corporate-resolution update. There is no active standalone growth story left.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。